Metabolix (MBLX)

Add to Watchlists Create an Alert
0.52 -0.08  -13.33% NASDAQ Jul 30, 8:00PM BATS Real time Currency in USD

Metabolix Research and Development Expense (Quarterly):

4.90M for March 31, 2014

View 4,000+ financial data types

View Full Chart

Metabolix Research and Development Expense (Quarterly) Chart

Export Data
Save Image

Metabolix Historical Research and Development Expense (Quarterly) Data

View and export this data going back to 2004. Start your YCharts Lite Membership
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
March 31, 2014 4.90M
Dec. 31, 2013 4.681M
Sept. 30, 2013 4.643M
June 30, 2013 4.945M
March 31, 2013 4.859M
Dec. 31, 2012 7.195M
Sept. 30, 2012 4.931M
June 30, 2012 5.006M
March 31, 2012 6.045M
Dec. 31, 2011 6.093M
Sept. 30, 2011 6.153M
June 30, 2011 6.00M
March 31, 2011
Dec. 31, 2010
Sept. 30, 2010
June 30, 2010
March 31, 2010
   
Dec. 31, 2009
Sept. 30, 2009
June 30, 2009
March 31, 2009
Dec. 31, 2008
Sept. 30, 2008 6.571M
June 30, 2008 6.008M
March 31, 2008 5.934M
Dec. 31, 2007 5.373M
Sept. 30, 2007 5.695M
June 30, 2007 5.026M
March 31, 2007 3.808M
Dec. 31, 2006 3.723M
Sept. 30, 2006 2.842M
June 30, 2006 2.537M
March 31, 2006 2.132M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

Get data for
Advertisement

MBLX Research and Development Expense (Quarterly) Benchmarks

Companies
Albemarle 22.57M
Cabot 16.00M
Chemtura 8.00M

MBLX Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 4.643M Sep 2013
Maximum 7.195M Dec 2012
Average 5.454M

MBLX Research and Development Expense (Quarterly) Excel Add-In Codes

  • Metric Code: r_and_d_expense
  • Latest data point: =YCP("MBLX", "r_and_d_expense")
  • Last 5 data points: =YCS("MBLX", "r_and_d_expense", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.